Correction to: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

• Maggie McCue,
• Sara Sarkey,
• Anna Eramo,
• Clement François,
• Sagar V. Parikh

Affiliations

Maggie McCue

Takeda Pharmaceuticals U.S.A., Inc.

Sara Sarkey

Takeda Pharmaceuticals U.S.A., Inc.

Anna Eramo

Lundbeck LLC

Clement François

Lundbeck LLC

Sagar V. Parikh

University of Michigan Health